This Article Full Text Full Text (PDF) A correction has been published All Versions of this Article: 19/5/1213    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bonamy, G. M. C. Articles by Allison, L. A. Search for Related Content PubMed PubMed Citation Articles by Bonamy, G. M. C. Articles by Allison, L. A.

Cancer Promoted by the Oncoprotein v-ErbA May Be Due to Subcellular Mislocalization of Nuclear Receptors

The College of William and Mary (G.M.C.B., L.A.A.), Department of Biology, Williamsburg, Virginia 23187; Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 693-Récepteurs Stéroïdiens, Physiopathologie endocrinienne et métabolique (G.M.C.B., A.G.M.), Faculté de Médecine Paris Sud, 94276 Le Kremlin-Bicetre Cedex France; and Université Paris 7-Denis-Diderot (G.M.C.B.), 75251 Paris Cedex 05, France

Address all correspondence and requests for reprints to: Lizabeth A. Allison, Department of Biology, College of William and Mary, P.O. Box 8795, Millington Hall 116, Williamsburg, Virginia 23187-8795. E-mail: laalli{at}wm.edu.

The retroviral v-ErbA oncoprotein is a highly mutated variant of the thyroid hormone receptor (TR), which is unable to bind T₃ and interferes with the action of TR in mammalian and avian cancer cells. v-ErbA dominant-negative activity is attributed to competition with TR for T₃-responsive DNA elements and/or auxiliary factors involved in the transcriptional regulation of T₃-responsive genes. However, competition models do not address the altered subcellular localization of v-ErbA and its possible implications in oncogenesis. Here, we report that v-ErbA dimerizes with TR and the retinoid X receptor and sequesters a significant fraction of the two nuclear receptors in the cytoplasm. Recruitment of TR to the cytoplasm by v-ErbA can be partially reversed in the presence of ligand and when chromatin is disrupted by the histone deacetylase inhibitor trichostatin A. These results define a new mode of action of v-ErbA and illustrate the importance of cellular compartmentalization in transcriptional regulation and oncogenesis.

NURSA Molecule Pages Link:

Nuclear Receptors:   TRα  |  RXRβ

Ligands:   9-cis-Retinoic acid  |  Thyroid hormone

This article has been cited by other articles:

				M. E. Grespin, G. M. C. Bonamy, V. R. Roggero, N. G. Cameron, L. E. Adam, A. P. Atchison, V. M. Fratto, and L. A. Allison Thyroid Hormone Receptor {alpha}1 Follows a Cooperative CRM1/Calreticulin-mediated Nuclear Export Pathway J. Biol. Chem., September 12, 2008; 283(37): 25576 - 25588. [Abstract] [Full Text] [PDF]

				H. Wallrabe, G. Bonamy, A. Periasamy, and M. Barroso Receptor Complexes Cotransported via Polarized Endocytic Pathways Form Clusters with Distinct Organizations Mol. Biol. Cell, June 1, 2007; 18(6): 2226 - 2243. [Abstract] [Full Text] [PDF]